Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-18 · accession 0001209191-23-059103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | 2023-12-18 | FATE | Dulac Edward J III | CFO | S - Sale | $3.50 | -1,585 | 118.0K | -1% | -$5,548 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-18 | S | D | 1,585 | $3.50 | 117,985 | D | — | — |